My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Sana Biotechnology, Inc. - Common Stock (NQ:SANA)

4.940 UNCHANGED

Streaming Delayed Price Updated: 4:15 PM EST, Dec 10, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Sana Biotechnology, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >

Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet ↗

January 12, 2024

A look at five stocks seeing increased attention from investors.

Via Benzinga

Aspen Aerogels Issues Business Update, Joins Plug Power, SunPower And Other Big Stocks Moving Lower On Thursday ↗

January 11, 2024

U.S. stocks traded lower, with the Dow Jones index falling over 150 points on Thursday. Shares of Aspen Aerogels, Inc. (NYSE: ASPN) fell sharply during Thursday’s session after the company issued a...

Via Benzinga

Topics Stocks

Why WD-40 Shares Are Trading Higher By Over 17%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

January 10, 2024

Shares of WD-40 Company (NASDAQ: WDFC) rose sharply during Wednesday’s session after the company reported better-than-expected first-quarter results.

Via Benzinga

Why Sana Biotechnology Shares Are Rising Today ↗

January 05, 2024

Sana Biotechnology, Inc. (NASDAQ: SANA) announced the U.S.

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

January 10, 2024

Via Benzinga

Sana Biotechnology Announces FDA Clearance of Investigational New Drug Application for SC262, a Hypoimmune-modified, CD22-directed Allogeneic CAR T Therapy, for Patients with Relapsed or Refractory B-cell Malignancies

January 05, 2024

Expect to disclose initial SC262 clinical data in 2024

From Sana Biotechnology, Inc

Via GlobeNewswire

Sana Biotechnology to Present at the 42nd Annual J.P. Morgan Healthcare Conference

January 03, 2024

From Sana Biotechnology, Inc

Via GlobeNewswire

Sana Biotechnology Highlights Preclinical Data Supporting Tumor Control and Immune Evasion Capabilities of Hypoimmune-Modified Allogeneic CAR T Cells in Presentations at the American Society of Hematology Annual Meeting

December 11, 2023

From Sana Biotechnology, Inc

Via GlobeNewswire

Why U Power Shares Are Trading Lower By Around 54%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

December 04, 2023

Shares of U Power Limited (NASDAQ: UCAR) shares moved lower during Monday’s session after the company announced pricing of registered follow-on offering of 10 million units at a purchase price of $1.20...

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

December 04, 2023

Via Benzinga

Sana Biotechnology Publishes Early Clinical Data Showing that SC291, a CD19-directed Allogeneic CAR T Therapy, Evades Immune Detection in Presence of Intact Immune System

December 01, 2023

From Sana Biotechnology, Inc

Via GlobeNewswire

Sana Biotechnology to Present at November and December 2023 Investor Conferences

November 21, 2023

From Sana Biotechnology, Inc

Via GlobeNewswire

Uppsala University Hospital and Sana Biotechnology Announce Authorization of the First-in-Human Clinical Trial Application for a Primary Islet Cell Treatment for Patients with Type 1 Diabetes

November 17, 2023

From Sana Biotechnology, Inc

Via GlobeNewswire

Sana Biotechnology Announces FDA Clearance of Investigational New Drug Application for SC291, a Hypoimmune-modified, CD19-directed Allogeneic CAR T Therapy, for Patients with Lupus Nephritis, Extrarenal Lupus, and ANCA-associated Vasculitis

November 09, 2023

From Sana Biotechnology, Inc

Via GlobeNewswire

Sana Biotechnology Reports Third Quarter 2023 Financial Results and Business Updates

November 08, 2023

From Sana Biotechnology, Inc

Via GlobeNewswire

Sana Biotechnology Announces Five Presentations at the 65th American Society of Hematology Annual Meeting

November 02, 2023

From Sana Biotechnology, Inc

Via GlobeNewswire

Sana Biotechnology Announces Increased Focus on Hypoimmune-Related Pipeline with the Potential to Deliver Clinical Proof of Concept Data from Four Programs in 2023 and 2024 with a 2024 Operating Burn under $200M

October 10, 2023

From Sana Biotechnology, Inc

Via GlobeNewswire

Benzinga's Top Ratings Upgrades, Downgrades For September 25, 2023 ↗

September 25, 2023

Via Benzinga

Why Eiger BioPharmaceuticals Shares Are Trading Lower By 52%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

September 13, 2023

Avalo Therapeutics, Inc. (NASDAQ: AVTX) shares surged 68% to $0.2075. Avalo Therapeutics, on Sept 12, got notice from the Nasdaq as of Sept 11 the company’s securities had closing bid price of...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

September 13, 2023

Via Benzinga

Sana Biotechnology to Present at September 2023 Investor Conferences

August 30, 2023

From Sana Biotechnology, Inc

Via GlobeNewswire

Benzinga's Top Ratings Upgrades, Downgrades For September 5, 2023 ↗

September 05, 2023

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For August 14, 2023 ↗

August 14, 2023

Via Benzinga

Sana Biotechnology Reports Second Quarter 2023 Financial Results and Business Updates

August 03, 2023

From Sana Biotechnology, Inc

Via GlobeNewswire

3 Hidden Penny Stocks That Could Turn $100 into $10,000 ↗

July 31, 2023

These penny stocks have multibagger upside potential with great margins of safety, according to Wall Street analysts.

Via InvestorPlace

Sana Biotechnology Highlights Preclinical Data from Hypoimmune and Fusogen Platforms at the International Society for Stem Cell Research (ISSCR) 2023 Annual Meeting

June 16, 2023

From Sana Biotechnology, Inc

Via GlobeNewswire

Sana Biotechnology to Present at June 2023 Investor Conferences

May 31, 2023

From Sana Biotechnology, Inc

Via GlobeNewswire

Why Nvidia Shares Are Trading Higher By Over 5%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

May 30, 2023

Gainers QualTek Services Inc. (NASDAQ: QTEK) shares jumped 127.2% to $0.1740 after dropping around 21% on Friday. Qualtek Services recently filed voluntarily petitions for Chapter 11 bankruptcy.

Via Benzinga

Skyline Champion, Atea Pharmaceuticals And Other Big Stocks Moving Lower On Tuesday ↗

May 30, 2023

U.S. stocks traded mixed, with the Dow Jones dropping over 100 points on Tuesday. Here are some big stocks recording losses in today’s session.

Via Benzinga

Why Venus Concept Shares Are Trading Lower By Over 15%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

May 15, 2023

Gainers NeoGames S.A. (NASDAQ: NGMS) shares climbed 113.3% to $27.38 as the company agreed to be acquired by Aristocrat Leisure Limited for $29.50 per share in cash.

Via Benzinga

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.